{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:26:39Z","timestamp":1795231599093,"version":"4.10.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Itaconate is a well-known immunomodulatory metabolite; however, its role in hepatocellular carcinoma (HCC) remains unclear. Here, we find that macrophage-derived itaconate promotes HCC by epigenetic induction of Eomesodermin (EOMES)-mediated CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell exhaustion. Our results show that the knockout of immune-responsive gene 1 (IRG1), responsible for itaconate production, suppresses HCC progression.\n                    <jats:italic>Irg1<\/jats:italic>\n                    knockout leads to a decreased proportion of PD-1\n                    <jats:sup>+<\/jats:sup>\n                    and TIM-3\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Deletion or adoptive transfer of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells shows that IRG1-promoted tumorigenesis depends on CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell exhaustion. Mechanistically, itaconate upregulates PD-1 and TIM-3 expression levels by promoting succinate-dependent H3K4me3 of the\n                    <jats:italic>Eomes<\/jats:italic>\n                    promoter. Finally, ibuprofen is found to inhibit HCC progression by targeting IRG1\/itaconate-dependent tumor immunoevasion, and high\n                    <jats:italic>IRG1<\/jats:italic>\n                    expression in macrophages predicts poor prognosis in HCC patients. Taken together, our results uncover an epigenetic link between itaconate and HCC and suggest that targeting IRG1 or itaconate might be a promising strategy for HCC treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-43988-4","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T04:02:03Z","timestamp":1702094523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion"],"prefix":"10.1038","volume":"14","author":[{"given":"Xuemei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinggen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-7531","authenticated-orcid":false,"given":"Huafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-7520","authenticated-orcid":false,"given":"Linchong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-7989","authenticated-orcid":false,"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"key":"43988_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J Clin."},{"key":"43988_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","volume":"372","author":"SM Ansell","year":"2015","unstructured":"Ansell, S. M. et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma. N. Engl. J. Med. 372, 311\u2013319 (2015).","journal-title":"N. Engl. J. Med."},{"key":"43988_CR3","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","volume":"372","author":"MA Postow","year":"2015","unstructured":"Postow, M. A. et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N. Engl. J. Med. 372, 2006\u20132017 (2015).","journal-title":"N. Engl. J. Med."},{"key":"43988_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151\u2013172 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"43988_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro, B., Sarobe, P., Herv\u00e1s-Stubbs, S. & Melero, I. Advances in immunotherapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18, 525\u2013543 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"43988_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41577-019-0128-5","volume":"19","author":"LAJ O\u2019Neill","year":"2019","unstructured":"O\u2019Neill, L. A. J. & Artyomov, M. N. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat. Rev. Immunol. 19, 273\u2013281 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"43988_CR7","doi-asserted-by":"crossref","unstructured":"Peace, C. G. & O\u2019Neill, L. A. The role of itaconate in host defense and inflammation. J. Clin. Invest. 132, e148548 (2022).","DOI":"10.1172\/JCI148548"},{"key":"43988_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s42255-018-0014-7","volume":"1","author":"DG Ryan","year":"2019","unstructured":"Ryan, D. G. et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat. Metab. 1, 16\u201333 (2019).","journal-title":"Nat. Metab."},{"key":"43988_CR9","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl Acad. Sci. USA 110, 7820\u20137825 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"43988_CR10","doi-asserted-by":"publisher","first-page":"16386","DOI":"10.1021\/ja2070889","volume":"133","author":"CL Strelko","year":"2011","unstructured":"Strelko, C. L. et al. Itaconic acid is a mammalian metabolite induced during macrophage activation. J. Am. Chem. Soc. 133, 16386\u201316389 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"43988_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"43988_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","volume":"556","author":"M Bambouskova","year":"2018","unstructured":"Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6-ATF3 inflammatory axis. Nature 556, 501\u2013504 (2018).","journal-title":"Nature"},{"key":"43988_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","volume":"32","author":"A Hooftman","year":"2020","unstructured":"Hooftman, A. et al. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 32, 468\u2013478.e467 (2020).","journal-title":"Cell Metab."},{"key":"43988_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1126\/science.aaz1333","volume":"369","author":"M Chen","year":"2020","unstructured":"Chen, M. et al. Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella. Science 369, 450\u2013455 (2020).","journal-title":"Science"},{"key":"43988_CR15","doi-asserted-by":"publisher","first-page":"e1005408","DOI":"10.1371\/journal.ppat.1005408","volume":"12","author":"J Naujoks","year":"2016","unstructured":"Naujoks, J. et al. IFNs modify the proteome of Legionella-containing vacuoles and restrict infection via IRG1-derived itaconic acid. PLoS Pathog. 12, e1005408 (2016).","journal-title":"PLoS Pathog."},{"key":"43988_CR16","doi-asserted-by":"crossref","unstructured":"Price, J. V. et al. IRG1 and inducible nitric oxide synthase act redundantly with other interferon-gamma-induced factors to restrict intracellular replication of Legionella pneumophila. mBio 10, e02629-19 (2019).","DOI":"10.1128\/mBio.02629-19"},{"key":"43988_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.21037\/atm-21-1448","volume":"9","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. Itaconate ameliorates methicillin-resistant Staphylococcus aureus-induced acute lung injury through the Nrf2\/ARE pathway. Ann. Transl. Med. 9, 712 (2021).","journal-title":"Ann. Transl. Med."},{"key":"43988_CR18","doi-asserted-by":"crossref","unstructured":"Zeng, Y. R. et al. The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response. J. Clin. Invest. 133, e160463 (2023).","DOI":"10.1172\/JCI160463"},{"key":"43988_CR19","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth. Nat. Metab. 4, 1660\u20131673 (2022).","journal-title":"Nat. Metab."},{"key":"43988_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","volume":"55","author":"NM Chapman","year":"2022","unstructured":"Chapman, N. M. & Chi, H. Metabolic adaptation of lymphocytes in immunity and disease. Immunity 55, 14\u201330 (2022).","journal-title":"Immunity"},{"key":"43988_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","volume":"20","author":"SP Kubli","year":"2021","unstructured":"Kubli, S. P., Berger, T., Araujo, D. V., Siu, L. L. & Mak, T. W. Beyond immune checkpoint blockade: emerging immunological strategies. Nat. Rev. Drug Discov. 20, 899\u2013919 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"43988_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"43988_CR23","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"43988_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"43988_CR25","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.4049\/jimmunol.0804211","volume":"182","author":"JF Grosso","year":"2009","unstructured":"Grosso, J. F. et al. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J. Immunol. 182, 6659\u20136669 (2009).","journal-title":"J. Immunol."},{"key":"43988_CR26","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1073\/pnas.1003345107","volume":"107","author":"J Matsuzaki","year":"2010","unstructured":"Matsuzaki, J. et al. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc. Natl Acad. Sci. USA 107, 7875\u20137880 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"43988_CR27","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1084\/jem.20100637","volume":"207","author":"J Fourcade","year":"2010","unstructured":"Fourcade, J. et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 207, 2175\u20132186 (2010).","journal-title":"J. Exp. Med."},{"key":"43988_CR28","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187\u20132194 (2010).","journal-title":"J. Exp. Med."},{"key":"43988_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova, N. N., Zhu, J. & Thompson, C. B. The hallmarks of cancer metabolism: still emerging. Cell Metab. 34, 355\u2013377 (2022).","journal-title":"Cell Metab."},{"key":"43988_CR30","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad, G., Helmink, B. A., Sharma, P. & Wargo, J. A. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 184, 5309\u20135337 (2021).","journal-title":"Cell"},{"key":"43988_CR31","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","volume":"23","author":"JA Belk","year":"2022","unstructured":"Belk, J. A., Daniel, B. & Satpathy, A. T. Epigenetic regulation of T cell exhaustion. Nat. Immunol. 23, 848\u2013860 (2022).","journal-title":"Nat. Immunol."},{"key":"43988_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco, F., Jaccard, A., Romero, P., Yu, Y. R. & Ho, P. C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001\u20131012 (2020).","journal-title":"Nat. Metab."},{"key":"43988_CR33","doi-asserted-by":"publisher","first-page":"14274","DOI":"10.1074\/jbc.M115.685792","volume":"291","author":"T Cordes","year":"2016","unstructured":"Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274\u201314284 (2016).","journal-title":"J. Biol. Chem."},{"key":"43988_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmet.2018.09.003","volume":"29","author":"J Dom\u00ednguez-Andr\u00e9s","year":"2019","unstructured":"Dom\u00ednguez-Andr\u00e9s, J. et al. The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity. Cell Metab. 29, 211\u2013220.e215 (2019).","journal-title":"Cell Metab."},{"key":"43988_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab."},{"key":"43988_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41556-022-00853-8","volume":"24","author":"LL Chen","year":"2022","unstructured":"Chen, L. L. et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat. Cell Biol. 24, 353\u2013363 (2022).","journal-title":"Nat. Cell Biol."},{"key":"43988_CR37","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3389\/fimmu.2018.02981","volume":"9","author":"J Li","year":"2018","unstructured":"Li, J., He, Y., Hao, J., Ni, L. & Dong, C. High levels of Eomes promote exhaustion of anti-tumor CD8+ T cells. Front. Immunol. 9, 2981 (2018).","journal-title":"Front. Immunol."},{"key":"43988_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer 20, 218\u2013232 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"43988_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten, K. et al. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. Cancer Cell 40, 624\u2013638.e629 (2022).","journal-title":"Cancer Cell"},{"key":"43988_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s42255-020-0179-8","volume":"2","author":"ST Li","year":"2020","unstructured":"Li, S. T. et al. Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis. Nat. Metab. 2, 256\u2013269 (2020).","journal-title":"Nat. Metab."},{"key":"43988_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2012.06.001","volume":"16","author":"C Lu","year":"2012","unstructured":"Lu, C. & Thompson, C. B. Metabolic regulation of epigenetics. Cell Metab. 16, 9\u201317 (2012).","journal-title":"Cell Metab."},{"key":"43988_CR42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","volume":"184","author":"N Wang","year":"2021","unstructured":"Wang, N. et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell 184, 370\u2013383 (2021).","journal-title":"Cell"},{"key":"43988_CR43","doi-asserted-by":"publisher","first-page":"111193","DOI":"10.1016\/j.celrep.2022.111193","volume":"40","author":"N Gudgeon","year":"2022","unstructured":"Gudgeon, N. et al. Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation. Cell Rep. 40, 111193 (2022).","journal-title":"Cell Rep."},{"key":"43988_CR44","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/sj.onc.1203160","volume":"18","author":"ST Palayoor","year":"1999","unstructured":"Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N. & Price, B. D. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18, 7389\u20137394 (1999).","journal-title":"Oncogene"},{"key":"43988_CR45","doi-asserted-by":"publisher","first-page":"175256","DOI":"10.1016\/j.ejphar.2022.175256","volume":"933","author":"NY Zhang","year":"2022","unstructured":"Zhang, N. Y. et al. Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK\/NF-\u03baB and glutamatergic pathways. Eur. J. Pharmacol. 933, 175256 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"43988_CR46","doi-asserted-by":"publisher","first-page":"862582","DOI":"10.3389\/fcimb.2022.862582","volume":"12","author":"CCB Bomfim","year":"2022","unstructured":"Bomfim, C. C. B. et al. Mycobacterium tuberculosis induces Irg1 in murine macrophages by a pathway involving both TLR-2 and STING\/IFNAR signaling and requiring bacterial phagocytosis. Front. Cell Infect. Microbiol. 12, 862582 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"43988_CR47","doi-asserted-by":"crossref","unstructured":"Watson, M. J. & Delgoffe, G. M. Fighting in a wasteland: deleterious metabolites and antitumor immunity. J. Clin. Invest. 13, e148549 (2022).","DOI":"10.1172\/JCI148549"},{"key":"43988_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00807-3","volume":"8","author":"R He","year":"2022","unstructured":"He, R. et al. Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury. Cell Death Discov. 8, 43 (2022).","journal-title":"Cell Death Discov."},{"key":"43988_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","volume":"34","author":"MC Runtsch","year":"2022","unstructured":"Runtsch, M. C. et al. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab. 34, 487\u2013501.e488 (2022).","journal-title":"Cell Metab."},{"key":"43988_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s42255-022-00605-w","volume":"4","author":"EM Schuster","year":"2022","unstructured":"Schuster, E. M. et al. TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages. Nat. Metab. 4, 856\u2013866 (2022).","journal-title":"Nat. Metab."},{"key":"43988_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2017.09.051","volume":"171","author":"H Shen","year":"2017","unstructured":"Shen, H. et al. The human knockout gene CLYBL connects itaconate to vitamin B12. Cell 171, 771\u2013782.e711 (2017).","journal-title":"Cell"},{"key":"43988_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nchembio.1482","volume":"10","author":"J Sasikaran","year":"2014","unstructured":"Sasikaran, J., Ziemski, M., Zadora, P. K., Fleig, A. & Berg, I. A. Bacterial itaconate degradation promotes pathogenicity. Nat. Chem. Biol. 10, 371\u2013377 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"43988_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51, 27\u201341 (2019).","journal-title":"Immunity"},{"key":"43988_CR54","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3109\/10428194.2010.496506","volume":"51","author":"KL Borden","year":"2010","unstructured":"Borden, K. L. & Culjkovic-Kraljacic, B. Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? Leuk. Lymphoma 51, 1805\u20131815 (2010).","journal-title":"Leuk. Lymphoma"},{"key":"43988_CR55","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-03-3814","volume":"64","author":"F Khwaja","year":"2004","unstructured":"Khwaja, F., Allen, J., Lynch, J., Andrews, P. & Djakiew, D. Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. Cancer Res. 64, 6207\u20136213 (2004).","journal-title":"Cancer Res."},{"key":"43988_CR56","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1038\/onc.2011.655","volume":"31","author":"X Li","year":"2012","unstructured":"Li, X. et al. Sulindac inhibits tumor cell invasion by suppressing NF-\u03baB-mediated transcription of microRNAs. Oncogene 31, 4979\u20134986 (2012).","journal-title":"Oncogene"},{"key":"43988_CR57","first-page":"Cd012537","volume":"8","author":"C Eccleston","year":"2017","unstructured":"Eccleston, C., Cooper, T. E., Fisher, E., Anderson, B. & Wilkinson, N. M. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. Cochrane Database Syst. Rev. 8, Cd012537 (2017).","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-43988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-43988-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-43988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T05:02:48Z","timestamp":1702098168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-43988-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43988"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-43988-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8154"}}